Posted: Jul 14, 2020 at 6:23 pm ET Moderna headquarters in Cambridge, Massachusetts. fake pictures Moderna Inc.’s shares soared in the extended session Tuesday after the biotech company said its coronavirus vaccine candidate produced a “robust” immune system response in a larger group of people and the study will go …
Read More »
Text size Moderna’s headquarters in Cambridge, Massachusetts. Joseph Prezioso / AFP / Getty Images Moderna’s announcement of positive data about a Phase 1 trial of its Covid-19 vaccine in May was met with skepticism by some experts, who noted that the company had not included many details about the trial’s …
Read More »
Moderna Inc.’s shares soared in the extended session Tuesday after the biotech company said its coronavirus vaccine candidate produced a “robust” immune system response in a larger group of people and the study will go on to a decisive clinical trial in July. Results published in The New England Journal …
Read More »
Text size Maddie Meyer / Getty Images Moderna’s shares have risen 239% so far this year, and the biotech company, which has no approved medications, has a market capitalization of more than $ 24 billion. But in a note sent out Monday morning, Jefferies analyst Michael Yee writes that the …
Read More »
The 2020 coronavirus and the 1918 Spanish influenza pandemics share many similarities, but also diverge on one key point. “A big difference between the Spanish flu and COVID-19 is the age distribution of deaths,” according to Deutsche Bank DB, + 4.40%. “For COVID-19, the elderly have been overwhelmingly the most …
Read More »